Fit-for-purpose outsourcing models: Adapting to a world of untapped innovation and emerging risks

In today’s dynamic drug development landscape, selecting the right outsourcing strategy is critical for biopharma companies as they strive to bring treatments to market swiftly and efficiently. This playbook examines FSP, FSO, and hybrid models, with insights for choosing the optimal approach for clinical development goals and ultimately, success.

With a substantial increase in trials over the past five years and significant geographical diversification, biopharma companies face new criteria when considering an outsourcing strategy.

• What are the best ways to optimize trial design, enhance patient-guided development, and leverage technology effectively?
• How much control would you like to retain over day-to-day operations?
• How much flexibility will you need in staff resourcing?
• What technology, processes and regulatory strategy will support your path forward?

Whether opting for a full-service model, an FSP approach, or a bespoke, hybrid solution, we can help you prioritize your desired operating model while weighing the limitations and benefits of each approach.

Download to learn how we can help.

Get Exclusive PDF Access

Return to Insights Center